Ra. Peleman et al., Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia, ANTIM AG CH, 44(1), 2000, pp. 178-180
The penetration of trovafloxacin (TVA), 200 mg once daily, into the airways
of 17 patients with severe pneumonia was studied. The mean (standard devia
tions are given in parentheses) steady-state TVA concentrations, 2 h after
the last intake, were 3.1 (0.3) mg/liter in induced sputum (n = 8), 3.2 (1.
1) mg/liter in bronchial secretions (n = 9), 3.2 (0.9) mg/liter in bronchoa
lveolar lavage fluid (n = 10), and 4.9 (1.4) mg/liter in epithelial lining
fluid (n = 11).